CoChat
Sign Up
Cited by 132Tryptophan and brain disordersTreatment of Major DepressionStress Responses and Cortisol

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Treatment of cytokine-induced depression

Capuron, Lucile, Hauser, Peter, Hinze-Selch, Dunja, Miller, Andrew H, Neveu, Pierre J·2002·Brain Behavior and Immunity
DOI 10.1016/s0889-1591(02)00007-7
Open this paper in CoChat — free account

Abstract

A high proportion of cancer and hepatitis C patients who receive cytokine immunotherapy develop symptoms of depression that are indistinguishable from those found in major depressive disorders. These symptoms are alleviated by anti-depressant treatment. Moreover, preventive treatment with anti-depressants, in particular selective serotonin reuptake inhibitors (SSRIs) attenuates IFN-alpha-associated symptoms of depression, anxiety, and neurotoxicity. The intermediate mechanisms of these effects are still unclear. Studies suggest that the state of depression is associated with an increase in plasma levels of various cytokines and soluble cytokine receptors. Furthermore, anti-depressants have been shown to shift the cytokine network towards a decreased production of pro-inflammatory cytokines and an increased production of anti-inflammatory cytokines. Other studies suggest that anti-depressants can also modify immune reactivity by acting on neural structures involved in neuroimmunomodulation. It is possible that anti-depressants could help to normalize the serotoninergic neurotransmission that is likely disrupted during immunotherapy due to the potent effects of cytokines on the metabolism of the amino acid precursor tryptophan. Further work is needed to optimize strategies for preventing neuropsychiatric side effects of cytokine immunotherapy, to clarify the mechanisms involved in the alleviating effects of anti-depressants on cytokine-induced depression, as well as to assess the possible consequences of anti-depressant therapy on the efficacy of immunotherapy on the disease process.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0889-1591(02)00007-7

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 2

  1. Gumnick, 2001, The effects of paroxetine on interferon-α-induced neuropsychiatric and physical symptoms in patients witn malignant melanoma, Brain Behav. Immun., 15, 116
  2. Schuld, 2000, Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine, Schizophr. Res., 43, 154

Cited by

Sorted by citations

Items 101–132 of 132

Related

See all

Metadata

Authors
Capuron, L., Hauser, P., Hinze-Selch, D., Miller, A. H., & Neveu, P. J.
Affiliations
  • Emory University (US)
  • Université de Bordeaux (FR)
Corresponding author
Neveu, Pierre J
ORCID
Capuron, Lucile
Venue
Brain Behavior and Immunity
Publisher
Elsevier BV
Published
2002-10
Volume
16
Issue
5
Pages
575-580
ISSN
0889-1591 (ISSN-L)
DOI
10.1016/s0889-1591(02)00007-7
OpenAlex
W2002423129
Cited by
132
References
30
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 6 · 2019: 6 · 2018: 9 · 2017: 7 · 2016: 7 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 4
FWCI
0.66
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
cytokine therapy, antidepressants, selective serotonin reuptake inhibitors, interferon-alpha, cancer patients, hepatitis C, neurotoxicity, anxiety, neuroimmunomodulation, serotonergic neurotransmission, tryptophan metabolism, inflammatory cytokines, anti-inflammatory cytokines, soluble cytokine receptors, neuropsychiatric adverse effects
MeSH terms
Antidepressive Agents, Depressive Disorder, Humans, Immunotherapy, Serotonin, Sleep, Tryptophan, Cytokines, Receptors, Cytokine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review